Clinical nutrition for cancer care refers to the specialized dietary support and interventions tailored to meet the nutritional needs of cancer patients throughout their treatment journey. It involves the provision of personalized nutrition plans aimed at managing symptoms, optimizing treatment outcomes, and improving the overall quality of life for individuals undergoing cancer therapy.
Sizing and Forecast
The clinical nutrition for cancer care market size has grown strongly in recent years. It will grow from $4.67 billion in 2023 to $4.92 billion in 2024 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to raising awareness of nutritional needs, the emergence of precision nutrition approaches, changes in healthcare policy and reimbursement models, surgical interventions for cancer, and growing interest in functional foods, nutraceuticals, and dietary supplements.
The clinical nutrition for cancer care market size is expected to see strong growth in the next few years. It will grow to $6.14 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to a shift towards personalized medicine and precision nutrition approaches, increasing demand for clinical nutrition interventions to support patients, increasing awareness of the impact of nutrition on cancer treatment outcomes, advancements in cancer treatment, integrating structured clinical nutrition pathways in oncology. Major trends in the forecast period include advances in nutritional biomarker research, technological innovations in nutritional products and delivery systems, increased collaboration between oncologists, ongoing advancements in nutritional science, and continued research and development in nutritional science.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/clinical-nutrition-for-cancer-care-global-market-report
Segmentation & Regional Insights
The clinical nutrition for cancer care market covered in this report is segmented –
1) By Type: Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas
2) By Cancer Type: Head And Neck Cancer, Stomach And Gastrointestinal Cancers, Blood Cancer, Breast Cancer, Lung Cancer, Other Cancer Types
3) By Age Group: Adult, Pediatric
4) By Sales Channel: Online, Retail, Institutional Sales
North America was the largest region in the clinical nutrition for cancer care market in 2023. The regions covered in the clinical nutrition for cancer care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16017&type=smp
Major Driver Impacting Market Growth
The rising prevalence of cancer is expected to propel the growth of the clinical nutrition for cancer care market going forward. Cancer is a group of diseases characterized by uncontrolled cell growth and the potential to spread to other parts of the body. The rise in cancer cases is attributed to increased life expectancy, making a larger aging population more susceptible to cancer. Clinical nutrition for cancer care is used to provide specialized dietary management and nutritional support tailored to the unique needs of cancer patients, aiming to optimize treatment outcomes. For instance, in February 2024, according to the World Health Organization, a US-based intergovernmental organization, approximately 35 million new cancer cases were predicted in 2050, a 77% increase from the estimated 20 million cases in 2022. Therefore, the rising prevalence of cancer is driving the growth of the clinical nutrition for cancer care market.
Key Industry Players
Major companies operating in the clinical nutrition for cancer care market are Pfizer Inc., Bayer AG, Abbott Nutrition, GlaxoSmithKline plc, Reckitt Benckiser Group plc, Evonik Industries AG, Baxter International Inc., Otsuka Holdings Co. Ltd., B. Braun Melsungen AG, Koninklijke DSM N.V., Glanbia plc, Kyowa Kirin Co. Ltd, Nestle Health Science S.A., Danone Nutricia, BioGaia AB, Meiji Holdings Company Ltd., Hormel Health Labs, Victus Inc., Taiho Pharmaceutical Co. Ltd., Global Health Products Inc
The clinical nutrition for cancer care market report table of contents includes:
1. Executive Summary
- Clinical Nutrition For Cancer Care Market Characteristics
- Clinical Nutrition For Cancer Care Market Trends And Strategies
- Clinical Nutrition For Cancer Care Market – Macro Economic Scenario
- Global Clinical Nutrition For Cancer Care Market Size and Growth
.
32. Global Clinical Nutrition For Cancer Care Market Competitive Benchmarking
- Global Clinical Nutrition For Cancer Care Market Competitive Dashboard
- Key Mergers And Acquisitions In The Clinical Nutrition For Cancer Care Market
- Clinical Nutrition For Cancer Care Market Future Outlook and Potential Analysis
- Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
